These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 22547818)
1. Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling. Tan MJ; White EA; Sowa ME; Harper JW; Aster JC; Howley PM Proc Natl Acad Sci U S A; 2012 Jun; 109(23):E1473-80. PubMed ID: 22547818 [TBL] [Abstract][Full Text] [Related]
2. Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling. Brimer N; Lyons C; Wallberg AE; Vande Pol SB Oncogene; 2012 Oct; 31(43):4639-46. PubMed ID: 22249263 [TBL] [Abstract][Full Text] [Related]
3. Association of papillomavirus E6 proteins with either MAML1 or E6AP clusters E6 proteins by structure, function, and evolutionary relatedness. Brimer N; Drews CM; Vande Pol SB PLoS Pathog; 2017 Dec; 13(12):e1006781. PubMed ID: 29281732 [TBL] [Abstract][Full Text] [Related]
4. Genus beta human papillomavirus E6 proteins vary in their effects on the transactivation of p53 target genes. White EA; Walther J; Javanbakht H; Howley PM J Virol; 2014 Aug; 88(15):8201-12. PubMed ID: 24850740 [TBL] [Abstract][Full Text] [Related]
5. The human papillomavirus type 8 E6 protein interferes with NOTCH activation during keratinocyte differentiation. Meyers JM; Spangle JM; Munger K J Virol; 2013 Apr; 87(8):4762-7. PubMed ID: 23365452 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation. Meyers JM; Uberoi A; Grace M; Lambert PF; Munger K PLoS Pathog; 2017 Jan; 13(1):e1006171. PubMed ID: 28107544 [TBL] [Abstract][Full Text] [Related]
7. Cottontail rabbit papillomavirus E6 proteins: Interaction with MAML1 and modulation of the Notch signaling pathway. Lim J; Frecot DI; Stubenrauch F; Iftner T; Simon C Virology; 2022 Nov; 576():52-60. PubMed ID: 36155393 [TBL] [Abstract][Full Text] [Related]
8. Interactions between E6AP and E6 proteins from alpha and beta HPV types. Thomas M; Tomaić V; Pim D; Myers MP; Tommasino M; Banks L Virology; 2013 Jan; 435(2):357-62. PubMed ID: 23206439 [TBL] [Abstract][Full Text] [Related]
9. An enhanced triple fluorescence flow-cytometry-based assay shows differential activation of the Notch signaling pathway by human papillomavirus E6 proteins. Lim J; Straub E; Stubenrauch F; Iftner T; Schindler M; Simon C Sci Rep; 2022 Feb; 12(1):3000. PubMed ID: 35194094 [TBL] [Abstract][Full Text] [Related]
10. MAML1-induced HPV E6 oncoprotein stability is required for cellular proliferation and migration of cervical tumor-derived cells. Skelin J; Đukić A; Filić V; Hufbauer M; Akgül B; Thomas M; Banks L; Tomaić V J Med Virol; 2023 Mar; 95(3):e28624. PubMed ID: 36852660 [TBL] [Abstract][Full Text] [Related]
12. Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo. Oyama T; Harigaya K; Sasaki N; Okamura Y; Kokubo H; Saga Y; Hozumi K; Suganami A; Tamura Y; Nagase T; Koga H; Nishimura M; Sakamoto R; Sato M; Yoshida N; Kitagawa M Development; 2011 Dec; 138(23):5235-46. PubMed ID: 22069191 [TBL] [Abstract][Full Text] [Related]
13. HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage. Wallace NA; Robinson K; Howie HL; Galloway DA PLoS Pathog; 2012; 8(7):e1002807. PubMed ID: 22807682 [TBL] [Abstract][Full Text] [Related]
14. E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. Underbrink MP; Howie HL; Bedard KM; Koop JI; Galloway DA J Virol; 2008 Nov; 82(21):10408-17. PubMed ID: 18715924 [TBL] [Abstract][Full Text] [Related]
15. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Goodwin EC; DiMaio D Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078 [TBL] [Abstract][Full Text] [Related]
16. Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control. Connolly K; Manders P; Earls P; Epstein RJ Cancer Treat Rev; 2014 Mar; 40(2):205-14. PubMed ID: 24051018 [TBL] [Abstract][Full Text] [Related]
17. Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation. Conrady MC; Suarez I; Gogl G; Frecot DI; Bonhoure A; Kostmann C; Cousido-Siah A; Mitschler A; Lim J; Masson M; Iftner T; Stubenrauch F; Travé G; Simon C J Virol; 2020 Dec; 95(2):. PubMed ID: 33115863 [TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. Kao WH; Beaudenon SL; Talis AL; Huibregtse JM; Howley PM J Virol; 2000 Jul; 74(14):6408-17. PubMed ID: 10864652 [TBL] [Abstract][Full Text] [Related]
19. The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. Liu X; Yuan H; Fu B; Disbrow GL; Apolinario T; Tomaic V; Kelley ML; Baker CC; Huibregtse J; Schlegel R J Biol Chem; 2005 Mar; 280(11):10807-16. PubMed ID: 15655249 [TBL] [Abstract][Full Text] [Related]
20. The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes. Bedard KM; Underbrink MP; Howie HL; Galloway DA J Virol; 2008 Apr; 82(8):3894-902. PubMed ID: 18256157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]